Variants of the inosine triphosphate pyrophosphatase gene and relapse risk following treatment for HCV genotype 2/3

Authors

  • Chia-Yen Dai M.D., Ph.D.,

    1. Hepatobiliary Division, Department of Internal Medicine, Kaohsiung Medical University HospitalM Kaohsiung Medical University, Kaohsiung, Taiwan
    2. Hepatitis Center, Kaohsiung Medical University Hospital, Kaohsiung Medical University, Kaohsiung, Taiwan
    3. Department of Occupational and Environmental Medicine, Kaohsiung Medical University Hospital, Kaohsiung Medical University, Kaohsiung, Taiwan
    Search for more papers by this author
  • Wan-Long Chuang M.D., Ph.D.,

    1. Hepatobiliary Division, Department of Internal Medicine, Kaohsiung Medical University HospitalM Kaohsiung Medical University, Kaohsiung, Taiwan
    2. Hepatitis Center, Kaohsiung Medical University Hospital, Kaohsiung Medical University, Kaohsiung, Taiwan
    Search for more papers by this author
  • Ming-Lung Yu M.D., Ph.D.

    1. Hepatobiliary Division, Department of Internal Medicine, Kaohsiung Medical University HospitalM Kaohsiung Medical University, Kaohsiung, Taiwan
    2. Hepatitis Center, Kaohsiung Medical University Hospital, Kaohsiung Medical University, Kaohsiung, Taiwan
    Search for more papers by this author

  • Potential conflict of interest: Nothing to report.

No abstract is available for this article.

Ancillary